and user acceptanc Cognizant (NASDAQ: CTSH) has announced an expansion of its longstanding relationship with biopharmaceutical leader Gilead Sciences (NASDAQ: GILD) that aims to unlock even ...

FOSTER CITY, Calif., February 11, 2025--Gilead Sciences, Inc. (Nasdaq: GILD) announced today its results of operations for the fourth quarter and full year 2024. Cognizant (NASDAQ: CTSH ...

The expanded agreement aims to deliver greater cost leadership and productivity enhancement for Gilead while seeking to extract greater value from the existing relationship. Leveraging machine ...